Axcella Health Inc

(NASDAQ:AXLA)

Latest On Axcella Health Inc (AXLA):

Date/Time Type Description Signal Details
2023-05-04 22:40 ESTNewsAxcella Health GAAP EPS of -$0.05 beats by $0.11N/A
2023-03-31 01:41 ESTNewsAxcella Health GAAP EPS of -$0.33 misses by $0.04N/A
2023-02-15 21:57 ESTNewsAxcella rises 16% after receiving FDA clearance for long COVID fatigue treatment trialN/A
2023-01-24 00:47 ESTNewsAxcella surges 48% after hours as co submits drug application for long COVID treatmentN/A
2022-12-16 00:24 ESTNewsAxcella CFO to depart among 85% staff cut in program reprioritization, restructuringN/A
2022-11-01 22:53 ESTNewsAxcella Health GAAP EPS of -$0.34 beats by $0.04N/A
2022-11-01 22:52 ESTNewsAxcella Health Inc. (AXLA) Q3 2022 Earnings Call TranscriptN/A
2022-10-14 00:03 ESTNewsAxcella Therapeutics drops 9% on $34.2M stock offeringN/A
2022-09-29 23:01 ESTNewsAxcella adds 20% as mid-stage trial indicates potential of NASH therapyN/A
2022-08-12 15:29 ESTNewsAxcella Health GAAP EPS of -$0.40 misses by $0.02N/A
2022-08-02 12:20 ESTNewsAxcella stock soars 18% as AXA1125 shows benefit in long COVID patients in trialN/A
2022-05-27 17:00 ESTNewsAxcella terminates phase 2 trial, to focus on long-COVID, NASH programs; R&D exec departsN/A
2022-05-05 22:42 ESTNewsAxcella Health GAAP EPS of -$0.46N/A
2022-04-25 18:06 ESTNewsAxcella Health: Revisiting A Lottery TicketN/A
2022-03-30 14:56 ESTNewsAxcella Health GAAP EPS of -$0.46 misses by $0.01N/A
2022-03-30 14:56 ESTNewsAxcella Health Inc. (AXLA) CEO Bill Hinshaw on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-17 02:40 ESTNewsAxcella Therapeutics raises $25M through equity offeringN/A
2022-02-15 01:01 ESTNewsAxcella granted FDA’s Fast Track Designation for NASH candidateN/A
2022-02-07 18:25 ESTNewsAxcella Therapeutics picks industry veteran for CFO roleN/A
2022-01-06 09:24 ESTNewsAxcella Health updates on 2022 milestonesN/A
2021-12-06 11:53 ESTNewsNew medical chief at Axcella TherapeuticsN/A
2021-11-20 04:45 ESTNewsAxcella Health (AXLA) Investor Presentation - SlideshowN/A
2021-11-11 01:54 ESTNewsAxcella Health EPS beats by $0.05N/A
2021-10-27 13:55 ESTNewsAxcella Health climbs after positive mention on Barron’sN/A
2021-10-26 12:52 ESTNewsAxcella Therapeutics launches new clinical program for AXA1125 in Long COVIDN/A
2021-10-19 06:07 ESTNewsWarning: AXLA is at high risk of performing badlyN/A
2021-10-07 05:38 ESTNewsAXLA is at high risk of performing badlyN/A
2021-09-27 13:28 ESTNewsWarning: AXLA has been downgraded to Very BearishN/A
2021-09-17 14:25 ESTNewsWarning: AXLA has been downgraded to Very Bearish.N/A
2021-07-31 23:29 ESTNewsAxcella Health's (AXLA) CEO Bill Hinshaw on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-31 05:24 ESTNewsAxcella Health Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-29 14:30 ESTNewsAxcella Health EPS in-lineN/A
2021-07-20 21:07 ESTNewsAxcella soars 10% on positive AXA1665 data in overt hepatic encephalopathy studyN/A
2021-07-20 20:44 ESTNewsSTSA, AXLA, CVAC and CRBP among after-hours moversN/A
2021-07-20 20:31 ESTNewsAxcella initiates mid-stage AXA1665 overt hepatic encephalopathy studyN/A
2021-07-20 20:25 ESTNewsHologic upgraded on M&A strategy, Waters upgraded on CEO turnaround, and more in today's analyst actionN/A
2021-05-06 07:58 ESTNewsAxcella Health EPS beats by $0.01N/A
2021-04-13 10:17 ESTNewsAxcella's NASH treatment AXA1125 gets FDA IND clearanceN/A
2021-03-18 20:16 ESTFinancialsCompany financials have been released.Neutral
2021-03-18 12:10 ESTEarnings EstimateAn EPS average of -$0.43 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-18 12:10 ESTEarnings EstimateAn EPS average of -$2.55 is estimated for the 2022 year.Sell
2021-03-17 19:11 ESTNewsAxcella Health EPS misses by $0.04N/A
2021-03-17 19:10 ESTNewsAxcella Health's (AXLA) CEO Bill Hinshaw on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-24 04:28 ESTNewsFollowing Up On Axcella HealthN/A
2021-01-11 14:53 ESTNewsAxcella decides not to expand enrollment in AXA4010-001 following cohort 1 readoutN/A
2021-01-02 15:11 ESTFinancialsCompany financials have been released.Neutral
2020-12-13 03:17 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 11:17 ESTAnalyst RatingThe Analyst Target Price has increased from $14.63 to $16.11.Buy
2020-11-17 19:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:13 ESTFinancialsCompany financials have been released.Neutral

About Axcella Health Inc (AXLA):

Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

AXLA Quotes by TradingView

See Advanced Chart

General

  • Name Axcella Health Inc
  • Symbol AXLA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 66
  • Fiscal Year EndDecember
  • IPO Date2019-05-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.axcellahealth.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.77
  • Enterprise Value EBITDA 0.07
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.84
  • Next Year EPS Estimate -$2.31
  • Next Quarter EPS Estimate -$0.41
  • Return on Assets -33%
  • Return on Equity -83%
  • Earnings Per Share -$6.04
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 203.85 million
  • EBITDA -41691000
  • Analyst Target Price $16.11
  • Book Value Per Share $2.01
View More

Share Statistics

  • Shares Outstanding 37.54 million
  • Shares Float 16.95 million
  • % Held by Insiders 1728%
  • % Held by Institutions 67.19%
  • Shares Short 376560
  • Shares Short Prior Month 351183
  • Short Ratio 4.93
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • 52 Week High $7.73
  • 52 Week Low $2.45
  • 50 Day Moving Average 5.92
  • 200 Day Moving Average 5.3
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Axcella Health Inc (AXLA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Axcella Health Inc (AXLA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A-$0.40-$0.36-11.11%
2020-09-302020-11-12$N/A-$0.34-$0.4116.85%
2020-06-302020-08-05$N/A-$0.48-$0.5411.11%
2020-03-312020-05-11$N/A-$0.65-$0.7716.11%
2019-12-312020-03-23$N/A-$0.54-$0.6415.59%
2019-09-302019-11-12$N/A-$0.75-$0.71-5.77%
2019-06-302019-08-12$N/A-$0.95-$0.64-47.77%
2019-03-312019-06-20$N/A-$0.50-$0.49-2.67%

Axcella Health Inc (AXLA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 23.1 million 3.83 million N/A 10.34 million 12.6 million
Income Before Tax -15.19 million N/A N/A -15.01 million -15.71 million
Selling General Administrative -8.63 million 7.89 million N/A 4.13 million 2.75 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -14.08 million -11.63 million N/A -14.46 million -15.34 million
Operating Income -14.47 million -11.73 million N/A -14.46 million -15.34 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A -712000 N/A -549000 -373000
Net Income From Continuing Operations -15.19 million -12.44 million N/A -15.01 million -15.71 million
Net Income Applicable to Common Shares -15.19 million N/A -13.89 million N/A -15.71 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -3.2 million N/A N/A N/A N/A
Change to Liabilities -287000 -237000 N/A -1.65 million 1.9 million
Total Cash Flow from Investing Activities -3.2 million -59000 N/A -34000 -36000
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 6.59 million N/A N/A 113000 -385000
Change to Operating Activities 512000 -597000 N/A 2.21 million 1.32 million
Change in Cash -7.26 million N/A N/A -13.3 million -12.56 million
Total Cash from Operating Activities -10.66 million -12.52 million N/A -13.38 million -12.13 million
Depreciation 92000 N/A N/A 144000 154000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 1.46 million 2.09 million N/A 1.63 million 1.8 million
Capital Expenditures N/A N/A N/A 34000 55000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 34.21 million 31.39 million N/A 30.77 million 34.14 million
Total Stockholder Equity 75.38 million 88.76 million N/A 46.81 million 60.22 million
Other Current Liabilities N/A 58000 N/A N/A 465000
Total Assets 109.59 million 120.15 million N/A 77.58 million 94.36 million
Common Stock 75.38 million N/A 92.96 million N/A 24000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -272.61 million -257.42 million N/A N/A -216.09 million
Other Liabilities N/A N/A 31.59 million N/A 882000
Other Assets 2.26 million N/A 3.22 million N/A 211000
Cash 71.59 million N/A N/A 75.52 million 92.05 million
Total Current Liabilities 7.78 million 5.28 million N/A N/A 8.36 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A N/A 608000
Total Current Assets 109.02 million 119.68 million N/A 75.52 million 93.54 million
Long Term Investments N/A 3.19 million N/A N/A N/A
Net Tangible Assets 75.38 million N/A 92.96 million N/A 60.22 million
Short Term Investments 35.74 million N/A N/A N/A N/A
Long Term Debt 25.22 million N/A N/A N/A 24.9 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.29 million 1.13 million N/A N/A 2 million

Axcella Health Inc (AXLA) Chart:

Axcella Health Inc (AXLA) News:

Below you will find a list of latest news for Axcella Health Inc (AXLA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Axcella Health Inc (AXLA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest AXLA Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST100$2.15
Jun 13, 2022 7:58 PM EST100$2.135
Jun 13, 2022 7:58 PM EST4$2.125
Jun 13, 2022 7:59 PM EST44$2.115
Jun 13, 2022 7:59 PM EST100$2.115

Axcella Health Inc (AXLA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633070/999999999520001420/9999999995-20-001420-index.htm
2019-02-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633070/000000000019002596/0000000000-19-002596-index.htm
2019-05-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633070/000000000019007994/0000000000-19-007994-index.htm
2020-04-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633070/000000000020003078/0000000000-20-003078-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633070/000000000020005142/0000000000-20-005142-index.htm
2019-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000031506619001565/0000315066-19-001565-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000031506620000779/0000315066-20-000779-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000089924320004662/0000899243-20-004662-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000089924320013708/0000899243-20-013708-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000089924320013883/0000899243-20-013883-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000089924320024799/0000899243-20-024799-index.htm
2019-01-28DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1633070/000091205719000028/0000912057-19-000028-index.htm
2019-03-15DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1633070/000091205719000096/0000912057-19-000096-index.htm
2020-04-03DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1633070/000091205720000119/0000912057-20-000119-index.htm
2019-04-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1633070/000104746919002181/0001047469-19-002181-index.htm
2019-04-30S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1633070/000104746919002716/0001047469-19-002716-index.htm
2019-05-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1633070/000104746919002887/0001047469-19-002887-index.htm
2019-05-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1633070/000104746919002985/0001047469-19-002985-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1633070/000104746920002063/0001047469-20-002063-index.htm
2020-05-11S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1633070/000104746920002985/0001047469-20-002985-index.htm
2020-05-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1633070/000104746920003070/0001047469-20-003070-index.htm
2019-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465919023276/0001104659-19-023276-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027177/0001104659-19-027177-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027178/0001104659-19-027178-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027179/0001104659-19-027179-index.htm
2019-05-078-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1633070/000110465919027493/0001104659-19-027493-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027922/0001104659-19-027922-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027925/0001104659-19-027925-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027926/0001104659-19-027926-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027927/0001104659-19-027927-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027928/0001104659-19-027928-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027929/0001104659-19-027929-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027930/0001104659-19-027930-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027931/0001104659-19-027931-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027933/0001104659-19-027933-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027935/0001104659-19-027935-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027939/0001104659-19-027939-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027940/0001104659-19-027940-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027941/0001104659-19-027941-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027942/0001104659-19-027942-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919027943/0001104659-19-027943-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919029735/0001104659-19-029735-index.htm
2019-05-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919030271/0001104659-19-030271-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465919030275/0001104659-19-030275-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031775/0001104659-19-031775-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031776/0001104659-19-031776-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031777/0001104659-19-031777-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031779/0001104659-19-031779-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031781/0001104659-19-031781-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031782/0001104659-19-031782-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031783/0001104659-19-031783-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919031847/0001104659-19-031847-index.htm
2019-05-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919033115/0001104659-19-033115-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919037921/0001104659-19-037921-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919038420/0001104659-19-038420-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919039346/0001104659-19-039346-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919039864/0001104659-19-039864-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919041034/0001104659-19-041034-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919043970/0001104659-19-043970-index.htm
2019-08-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919047152/0001104659-19-047152-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919047154/0001104659-19-047154-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919047155/0001104659-19-047155-index.htm
2019-08-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919048029/0001104659-19-048029-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465919061677/0001104659-19-061677-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465919066830/0001104659-19-066830-index.htm
2019-11-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919067053/0001104659-19-067053-index.htm
2019-11-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919067054/0001104659-19-067054-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919069117/0001104659-19-069117-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075203/0001104659-19-075203-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075204/0001104659-19-075204-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075205/0001104659-19-075205-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075206/0001104659-19-075206-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075207/0001104659-19-075207-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075209/0001104659-19-075209-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465919075210/0001104659-19-075210-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920000885/0001104659-20-000885-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920007760/0001104659-20-007760-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920028089/0001104659-20-028089-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1633070/000110465920043111/0001104659-20-043111-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1633070/000110465920056218/0001104659-20-056218-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465920057195/0001104659-20-057195-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465920058793/0001104659-20-058793-index.htm
2020-05-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465920059632/0001104659-20-059632-index.htm
2020-05-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465920059639/0001104659-20-059639-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465920063183/0001104659-20-063183-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465920064231/0001104659-20-064231-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920064239/0001104659-20-064239-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065465/0001104659-20-065465-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065466/0001104659-20-065466-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065468/0001104659-20-065468-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065469/0001104659-20-065469-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065471/0001104659-20-065471-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065472/0001104659-20-065472-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065473/0001104659-20-065473-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920065474/0001104659-20-065474-index.htm
2020-06-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920070299/0001104659-20-070299-index.htm
2020-06-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1633070/000110465920070391/0001104659-20-070391-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920071038/0001104659-20-071038-index.htm
2020-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633070/000110465920071707/0001104659-20-071707-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1633070/000110465920072939/0001104659-20-072939-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000110465920100496/0001104659-20-100496-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920102268/0001104659-20-102268-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920106516/0001104659-20-106516-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000110465920111050/0001104659-20-111050-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000114036120002598/0001140361-20-002598-index.htm
2019-05-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633070/000119312519155349/0001193125-19-155349-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000119312520025412/0001193125-20-025412-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000119312520035192/0001193125-20-035192-index.htm
2020-05-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633070/000119312520147454/0001193125-20-147454-index.htm
2020-05-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000119312520148794/0001193125-20-148794-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633070/000119312520242377/0001193125-20-242377-index.htm
2019-05-08CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1633070/000135445719000263/0001354457-19-000263-index.htm
2019-03-15DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1633070/000141057819000133/0001410578-19-000133-index.htm
2015-02-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307015000001/0001633070-15-000001-index.htm
2015-05-28D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307015000002/0001633070-15-000002-index.htm
2015-09-15D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307015000003/0001633070-15-000003-index.htm
2016-02-24D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307016000004/0001633070-16-000004-index.htm
2016-02-24DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307016000005/0001633070-16-000005-index.htm
2017-02-24D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307017000002/0001633070-17-000002-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307019000005/0001633070-19-000005-index.htm
2019-06-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633070/000163307019000008/0001633070-19-000008-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307019000014/0001633070-19-000014-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633070/000163307019000015/0001633070-19-000015-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307019000018/0001633070-19-000018-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307019000023/0001633070-19-000023-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633070/000163307019000025/0001633070-19-000025-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307019000027/0001633070-19-000027-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307020000002/0001633070-20-000002-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633070/000163307020000004/0001633070-20-000004-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307020000010/0001633070-20-000010-index.htm
2020-03-2310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1633070/000163307020000012/0001633070-20-000012-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307020000020/0001633070-20-000020-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633070/000163307020000022/0001633070-20-000022-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633070/000163307020000029/0001633070-20-000029-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633070/000163307020000031/0001633070-20-000031-index.htm
2019-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633070/999999999519001045/9999999995-19-001045-index.htm
2020-05-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633070/999999999520001153/9999999995-20-001153-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633070/999999999520001420/9999999995-20-001420-index.htm

Axcella Health Inc (AXLA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axcella Health Inc (AXLA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1728%
Institutional Ownership: 6719%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-01-17Catherine A. SohnDirectorBuy1,000.004.874,870.001,000.00https://www.sec.gov/Archives/edgar/data/1633070/000163307020000002/0001633070-20-000002-index.htm
2020-05-18Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy380,000.004.751,805,000.001,056,752.00https://www.sec.gov/Archives/edgar/data/1633070/000089924320013708/0000899243-20-013708-index.htm
2020-05-18David R EpsteinDirectorBuy50,000.004.75237,500.00118,103.00https://www.sec.gov/Archives/edgar/data/1633070/000110465920064239/0001104659-20-064239-index.htm
2019-06-26David R EpsteinDirectorBuy14,500.009.57138,765.0014,500.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919037921/0001104659-19-037921-index.htm
2019-06-27David R EpsteinDirectorBuy100.009.15915.0014,600.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919038420/0001104659-19-038420-index.htm
2019-07-01David R EpsteinDirectorBuy1,000.008.748,735.0015,500.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039346/0001104659-19-039346-index.htm
2019-07-02David R EpsteinDirectorBuy3,500.008.7730,677.5019,000.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039346/0001104659-19-039346-index.htm
2019-07-03David R EpsteinDirectorBuy56.008.99503.4419,056.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039346/0001104659-19-039346-index.htm
2019-06-28David R EpsteinDirectorBuy5,400.0010.0454,216.0020,000.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919038420/0001104659-19-038420-index.htm
2019-07-08David R EpsteinDirectorBuy274.009.002,466.0024,830.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039864/0001104659-19-039864-index.htm
2020-05-18Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy1,900,000.004.759,025,000.002,886,023.00https://www.sec.gov/Archives/edgar/data/1633070/000089924320013708/0000899243-20-013708-index.htm
2019-07-09David R EpsteinDirectorBuy4,200.008.2434,608.0029,030.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039864/0001104659-19-039864-index.htm
2019-07-10David R EpsteinDirectorBuy1,322.008.0710,668.5430,352.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919039864/0001104659-19-039864-index.htm
2020-01-24Laurent ChardonnetChief Financial OfficerBuy313.004.921,539.96313.00https://www.sec.gov/Archives/edgar/data/1633070/000110465920007760/0001104659-20-007760-index.htm
2019-07-17David R EpsteinDirectorBuy1,000.007.557,550.0031,352.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919041034/0001104659-19-041034-index.htm
2019-08-01David R EpsteinDirectorBuy4,092.006.9828,562.1635,444.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919043970/0001104659-19-043970-index.htm
2020-01-31Laurent ChardonnetChief Financial OfficerBuy3,000.004.9414,820.003,665.00https://www.sec.gov/Archives/edgar/data/1633070/000163307020000004/0001633070-20-000004-index.htm
2019-08-02David R EpsteinDirectorBuy2,849.007.0420,056.9638,293.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919043970/0001104659-19-043970-index.htm
2020-05-18Nestle Health Science US Holdings, Inc.10% Share HolderBuy1,936,842.004.759,199,999.504,305,541.00https://www.sec.gov/Archives/edgar/data/1633070/000089924320013883/0000899243-20-013883-index.htm
2020-05-18Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy1,520,000.004.757,220,000.004,808,780.00https://www.sec.gov/Archives/edgar/data/1633070/000089924320013708/0000899243-20-013708-index.htm
2019-11-26David R EpsteinDirectorBuy14,000.003.5549,700.0052,293.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919069117/0001104659-19-069117-index.htm
2019-11-27David R EpsteinDirectorBuy1,005.003.913,929.5553,298.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919069117/0001104659-19-069117-index.htm
2020-02-27David R EpsteinDirectorBuy12,800.003.6546,720.0066,098.00https://www.sec.gov/Archives/edgar/data/1633070/000110465920028089/0001104659-20-028089-index.htm
2020-01-27Laurent ChardonnetChief Financial OfficerBuy352.004.941,738.88665.00https://www.sec.gov/Archives/edgar/data/1633070/000110465920007760/0001104659-20-007760-index.htm
2020-02-28David R EpsteinDirectorBuy2,005.003.757,518.7568,103.00https://www.sec.gov/Archives/edgar/data/1633070/000110465920028089/0001104659-20-028089-index.htm
2019-05-13Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy500,000.0020.0010,000,000.00986,023.00https://www.sec.gov/Archives/edgar/data/1633070/000110465919029735/0001104659-19-029735-index.htm